Ascletis Pharma Inc.
1672
शेयरों में रैंक
#10750
Ascletis Pharma Inc., a biotechnology company, engages in the research and... Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People’s Republic of China.
शेयर मूल्य
$0.70283519
मार्केट कैप
$737.74M
बदलाव (1 दिन)
-7.39%
बदलाव (1 वर्ष)
-39.41%
देश
CN
व्यापार Ascletis Pharma Inc. (1672)
श्रेणी
Healthcare
Ascletis Pharma Inc. (1672) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.91 (2026-10-01 को)
दिन का सबसे निम्न समापन मूल्य: $0.60 (2019-11-01 को)
दिन का सबसे निम्न समापन मूल्य: $0.60 (2019-11-01 को)
Ascletis Pharma Inc. के स्टॉक मूल्य का इतिहास 2019 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
| वर्ष | प्रदर्शन |
|---|---|
| 2026 (TTM) | -10.90% |
| 2025 | 759.36% |
| 2024 | 9.90% |
| 2023 | -65.45% |
| 2022 | 11,939.80% |
| 2021 | -98.81% |
| 2020 | -40.55% |
| 2019 | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
| कंपनी | स्टॉक मूल्य | परिवर्तन 1व% | देश |
|---|---|---|---|
| $536.91 | 25.90% |
US
|
|
| $230.20 | 757.36% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $892.44 | 9.61% |
NL
|
|
| $291.76 | 2.51% |
BE
|
